Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1542, 2006-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pardoprunox monotherapy may provide benefit for patients with early-stage Parkinson's disease
Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. :
Ancrod may not provide clinical benefit to patients with acute ischaemic stroke
Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. :
Zoledronic acid may be effective in patients with SAPHO syndrome resistant to conventional therapy
Inpharma, Vol. 1, Iss. 1463, 2004-01 ,pp. :
In patients with rheumatoid arthritis (RA) "cholesterol-reducing therapies may be beneficial"
Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. :